CCORF Maintains Delcath Systems(DCTH.US) With Buy Rating, Maintains Target Price $21
Craig-Hallum Maintains Delcath Systems(DCTH.US) With Buy Rating
H.C. Wainwright Maintains Delcath Systems(DCTH.US) With Buy Rating, Maintains Target Price $22
Delcath Systems: Strong Financial Performance and Strategic Growth Drive Buy Rating
Craig-Hallum Maintains Delcath Systems(DCTH.US) With Buy Rating, Announces Target Price $11
Craig-Hallum Maintains Delcath Systems(DCTH.US) With Buy Rating
Craig-Hallum Maintains Delcath Systems(DCTH.US) With Buy Rating
Craig-Hallum Maintains Delcath Systems(DCTH.US) With Buy Rating
Craig-Hallum Maintains Delcath Systems(DCTH.US) With Buy Rating
Analysts Offer Insights on Healthcare Companies: Apyx Medical (APYX) and Delcath Systems (DCTH)
Delcath Systems Is Maintained at Buy by Canaccord Genuity
CCORF Maintains Delcath Systems(DCTH.US) With Buy Rating, Maintains Target Price $21
Delcath Systems Analyst Ratings
H.C. Wainwright Maintains Delcath Systems(DCTH.US) With Buy Rating, Maintains Target Price $22
Delcath Systems: Buy Rating Affirmed on Strong Q3 Results and Growth Prospects
CCORF Maintains Delcath Systems(DCTH.US) With Buy Rating, Maintains Target Price $21
CCORF Maintains Delcath Systems(DCTH.US) With Buy Rating, Maintains Target Price $21
Craig-Hallum Maintains Delcath Systems(DCTH.US) With Buy Rating
CCORF Maintains Delcath Systems(DCTH.US) With Buy Rating, Maintains Target Price $21
Buy Rating Affirmed for Delcath Systems Amidst Strong Hepzato Launch and Promising Future Prospects